title: Percutaneous treatment of iliac aneurysms and pseudoaneurysms with Cragg Endopro System 1 stent-grafts.
abstract: OBJECTIVE
  To evaluate the feasibility and short-term follow-up results of treating iliac aneurysms by the Cragg Endopro System 1 stent-graft.
  
  
  METHODS
  Nine lesions (two pseudoaneurysms and seven atherosclerotic aneurysms) were treated in eight patients by percutaneous implantation of a total of 10 stent-grafts. The procedure was followed by anticoagulation with heparin for 6 days, then antiplatelet therapy. Follow-up was by color Doppler ultrasound scan at 2 days and 3 months after the procedure for all patients, and by venous digital subtraction angiography and/or angio-CT up to 12 months later for four patients.
  
  
  RESULTS
  Initial clinical success rate was 100% and there were two minor complications. In one case the delivery system was faulty resulting in failure to deploy the stent-graft. An additional device had to be used. At 3-12 months all prostheses were patent but one patient (12.5%) had a minimal pergraft leak.
  
  
  CONCLUSIONS
  Percutaneous stent-grafting with this device is a safe and efficacious treatment of iliac artery aneurysms.
authors.affiliation: Institute of Radiology, Division of Vascular and Interventional Radiology, Azienda Ospedaliera S. Maria della Misericordia, Piazza S. Maria M, I-33100 Udine, Italy.
authors.forename: D
authors.initials: D
authors.lastname: Gasparini
authors.forename: A
authors.initials: A
authors.lastname: Lovaria
authors.forename: S
authors.initials: S
authors.lastname: Saccheri
authors.forename: A
authors.initials: A
authors.lastname: Nicolini
authors.forename: G
authors.initials: G
authors.lastname: Favini
authors.forename: L
authors.initials: L
authors.lastname: Inglese
authors.forename: P L
authors.initials: PL
authors.lastname: Giorgetti
authors.forename: P T
authors.initials: PT
authors.lastname: Basadonna
mesh_terms: D000368:Aged; D017541:Aneurysm, False / Q000000981:diagnostic imaging / Q000628:therapy*; D015901:Angiography, Digital Subtraction; D000925:Anticoagulants / Q000627:therapeutic use; D001161:Arteriosclerosis / Q000628:therapy; D001807:Blood Vessel Prosthesis; D004867:Equipment Design; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D017543:Iliac Aneurysm / Q000000981:diagnostic imaging / Q000628:therapy*; D008297:Male; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D015607:Stents; D013997:Time Factors; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome
chemical_list: D000925:Anticoagulants; D010975:Platelet Aggregation Inhibitors